Ireland, with its globally integrated pharmaceutical sector, looks poised to benefit from this week’s reform of the EU’s pharma legislation, which aims to enhance access to medicines, foster innovation, and strengthen supply chain resilience.

On Wednesday, the European Council endorsed a sweeping overhaul of the EU’s pharma framework, marking the most significant reform of the bloc’s regulatory framework in over two decades. The agreement paves the way for trilogue negotiations with the European Parliament and the European Commission.

A spokesperson for Ireland’s Department of Health welcomed the Council’s mandate, telling Euractiv it is a “significant milestone” in modernising the EU’s pharmaceutical landscape. “The outcome of these negotiations will be of vital importance to patients,

See Full Page